[HTML][HTML] The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research …

N Leung, F Bridoux, V Batuman, A Chaidos… - Nature Reviews …, 2019 - nature.com
The term monoclonal gammopathy of renal significance (MGRS) was introduced by the
International Kidney and Monoclonal Gammopathy Research Group (IKMG) in 2012. The …

[HTML][HTML] Daratumumab-based treatment for immunoglobulin light-chain amyloidosis

E Kastritis, G Palladini, MC Minnema… - … England Journal of …, 2021 - Mass Medical Soc
Background Systemic immunoglobulin light-chain (AL) amyloidosis is characterized by
deposition of amyloid fibrils of light chains produced by clonal CD38+ plasma cells …

[HTML][HTML] Quantitative serum free light chain assay–analytical issues

J Tate, S Bazeley, S Sykes, P Mollee - The Clinical Biochemist …, 2009 - ncbi.nlm.nih.gov
Serum free light chain (FLC) assay is an important advance in the diagnosis and monitoring
of monoclonal light chain diseases and a complementary test to serum protein …

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international …

R Trappe, S Oertel, V Leblond, P Mollee… - The lancet …, 2012 - thelancet.com
Background Post-transplantation lymphoproliferative disorder (PTLD) develops in 1–10% of
transplant recipients and can be Epstein–Barr virus (EBV) associated. To improve long-term …

Managing haematology and oncology patients during the COVID‐19 pandemic: interim consensus guidance

R Weinkove, ZK McQuilten, J Adler… - Medical Journal of …, 2020 - Wiley Online Library
Introduction A pandemic coronavirus, SARS‐CoV‐2, causes COVID‐19, a potentially life‐
threatening respiratory disease. Patients with cancer may have compromised immunity due …

Considerations for pre‐transfusion immunohaematology testing in patients receiving the anti‐CD38 monoclonal antibody daratumumab for the treatment of multiple …

H Quach, S Benson, H Haysom… - Internal Medicine …, 2018 - Wiley Online Library
In recent years, the anti‐CD38 monoclonal antibody daratumumab (Darzalex; Janssen‐
Cilag Pty Ltd) has been shown to be highly efficacious in relapsed and refractory multiple …

Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study

WP Law, WYS Wang, PT Moore… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Our aim was to determine the feasibility of 18F-florbetaben PET in diagnosing cardiac
amyloidosis. Methods: 18F-florbetaben PET was performed on 14 patients: 5 amyloid light …

Bortezomib, melphalan, and dexamethasone for light-chain amyloidosis

E Kastritis, X Leleu, B Arnulf, E Zamagni… - Journal of Clinical …, 2020 - discovery.ucl.ac.uk
PURPOSE: Oral melphalan and dexamethasone (MDex) were considered a standard of
care in light-chain (AL) amyloidosis. In the past decade, bortezomib has been increasingly …

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma

MK Gandhi, E Lambley, J Burrows, U Dua, S Elliott… - Clinical Cancer …, 2006 - AACR
Abstract Purpose: Latent Epstein-Barr virus (EBV) genomes are found in the malignant cells
of approximately one-third of Hodgkin's lymphoma (HL) cases. Detection and quantitation of …

Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines

V Sanchorawala, M Boccadoro, M Gertz, U Hegenbart… - Amyloid, 2022 - Taylor & Francis
AL amyloidosis is a systemic amyloidosis and is associated with an underlying plasma cell
dyscrasia. High dose intravenous melphalan and autologous stem cell transplantation was …